Award’s namesake, 103-year-old rheumatologist Ephraim P. Engleman, MD, met 10 winners of research funding established in his name by the Rheumatology Research Foundation in 2006
Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection
How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved
Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation
Understanding the Role of Citrullination in Rheumatoid Arthritis
Activation of peptidylarginine deiminases during complement and perforin activity may be at the core of citrullinated autoantigen production in RA.
Synthetic Hydrogel (aka Squishy Gel) Could Revolutionize Arthritis Treatment
Squishy gel could include a chemical compound capable of helping repair, restore or regenerate cartilage in a joint.
MicroRNA-Based Therapeutics Hold Promise Against Lupus, Other Rheumatic Diseases Note Experts at the ACR/ARHP’s 2013 Annual Meeting
Studies suggest deregulation, dysfunction of miRNAs in human, mice models of lupus may be future targets for gene therapy
Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium
Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA
Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments
Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis
Can Scleroderma Be Cured by Curing Cancer?
Research review
Research Into Causes of Systemic Vasculitis May Lead to Targeted Treatments Say Rheumatologists at the 2013 ACR/ARHP Annual Meeting
Studies focused on role of the immune system in disease development, and contributing genetic and environmental factors, may elicit better therapeutic approaches to small- and large-vessel vasculitis
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 125
- Next Page »